glp-1's Understanding semaglutide (GLP-1 RA): Are they the right choice for weight loss? How hospitalists can manage GLP-1s

The program also offers dose titration guidance based on tolerance and response

Awareness prevents these issues

Both treat diabetes

dosage should be reduced in patients with renal impairment no dosage adjustment required for mild to moderate hepatic insufficiency Side Effects: upper respiratory infection pancreatitis - there have been post-marketing reports of acute pancreatitis

The product half-life is 2.4 hours, which allows for twice-daily administration, and is a large improvement over endogenous GLP-1 [19]

Tell colleagues This educational programme has been supported by: This educational programme has been independently sponsored by the Boehringer Ingelheim and Lilly (BI & Lilly) Alliance